Works matching Progression-free survival

Results: 5000
    1

    Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.

    Published in:
    Bulletin of Experimental Biology & Medicine, 2020, v. 169, n. 4, p. 486, doi. 10.1007/s10517-020-04915-5
    By:
    • Zavarykina, T. M.;
    • Tyulyandina, A. S.;
    • Khokhlova, S. V.;
    • Khabas, G. N.;
    • Asaturova, A. V.;
    • Nosova, Yu. A.;
    • Brenner, P. K.;
    • Kapralova, M. A.;
    • Atkarskaya, M. V.;
    • Khodyrev, D. S.;
    • Burdennyi, A. M.;
    • Loginov, V. I.;
    • Stenina, M. B.;
    • Sukhikh, G. T.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 574, doi. 10.1002/hon.3082
    By:
    • Varettoni, Marzia;
    • Zibellini, Silvia;
    • Merli, Michele;
    • Drandi, Daniela;
    • Jiménez, Cristina;
    • Furlan, Daniela;
    • Ferretti, Virginia Valeria;
    • Fabbri, Nicole;
    • Dogliotti, Irene;
    • Varraso, Chiara;
    • Ferrante, Martina;
    • Cappello, Emilia;
    • Peri, Veronica;
    • Cavalloni, Chiara;
    • Borriero, Michela;
    • Facchetti, Giulia Vittoria;
    • Ferrero, Simone;
    • Arcaini, Luca;
    • Garcia‐Sanz, Ramon
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 9, p. 730, doi. 10.1111/iju.15133
    By:
    • Sato, Ryo;
    • Inamoto, Teruo;
    • Matsushita, Yuto;
    • Takemura, Ayana;
    • Uchimoto, Taizo;
    • Sano, Asuka;
    • Tanaka, Hiroki;
    • Ishikawa, Gaku;
    • Watanabe, Kyohei;
    • Watanabe, Hiromitsu;
    • Tamura, Keita;
    • Motoyama, Daisuke;
    • Sugiyama, Takayuki;
    • Otsuka, Atsushi;
    • Harada, Ken‐ichi;
    • Azuma, Haruhito;
    • Miyake, Hideaki
    Publication type:
    Article
    40

    Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1146008
    By:
    • Vázquez-Romo, Rafael;
    • Millan-Catalan, Oliver;
    • Ruíz-García, Erika;
    • Martínez-Gutiérrez, Antonio D.;
    • Alvarado-Miranda, Alberto;
    • Campos-Parra, Alma D.;
    • López-Camarillo, César;
    • Jacobo-Herrera, Nadia;
    • López-Urrutia, Eduardo;
    • Guardado-Estrada, Mariano;
    • León, David Cantúde;
    • Pérez-Plasencia, Carlos
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 10, p. 2516, doi. 10.1080/10428194.2019.1594219
    By:
    • Biccler, Jorne L.;
    • Savage, Kerry J.;
    • Brown, Peter D.N.;
    • Jørgensen, Judit;
    • Larsen, Thomas S.;
    • Poulsen, Christian B.;
    • Stoltenberg, Danny;
    • Sehn, Laurie H.;
    • Scott, David W.;
    • Gerrie, Alina S.;
    • Jakobsen, Lasse H.;
    • Bøgsted, Martin;
    • El-Galaly, Tarec C.;
    • Villa, Diego
    Publication type:
    Article
    47
    48
    49
    50